PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12972984::ACT039567

MAVP

Evidence text

Paper-level observation

in vitro q-PCR assays demonstrated that both MAVP and VP significantly suppressed the production of inflammatory cytokines in pro-inflammatory HUVECs (Fig. S14).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Anti-inflammatory
Measure
percent_inhibition
Comparator
=
Raw observation
significantly suppressed production of inflammatory cytokines (TNF-α, IL-1β, CCL-2, IL-12a)
Normalized measurement
=1
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
HUVEC
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.